GSM gold starGSM Global
中文版 · Chinese

bioQuad Recalls Two Lots of OsteoDenx Capsules Over Undeclared Milk, FDA Notice Says

Friday, November 13, 2026 · Life · GSM News

The U.S. Food and Drug Administration (FDA) posted a company announcement on November 13, 2026, stating that bioQuad Life Sciences of Yorba Linda, in Orange County, California, is recalling two lots of OsteoDenx dietary supplement capsules because they contain undeclared milk.

People who have an allergy or severe sensitivity to milk run the risk of a serious or life-threatening allergic reaction if they consume this product. The capsules contain lactoferrin derived from cow's milk, and the issue was identified during a routine FDA inspection. No illnesses have been reported to date.

The recalled lots are LOT#0524100 and LOT#0625041. The 30-capsule carton carries UPC 8 57294 00722 8, with expiration dates of 05/2027 and 08/2028, and the 60-capsule carton carries UPC 8 57294 00734 1. Cartons sold on Amazon.com carry two additional UPCs, 8 57294 00725 9 and 8 57294 00724 2.

The product was distributed nationwide from November 1, 2024 to November 11, 2026, through online orders at bioquad.com and Amazon.com, resellers, and a dental clinic in Redwood City, California. Distribution has stopped until corrected cartons are available.

Consumers who are allergic or sensitive to milk should not take the product and may discard it. Customers who purchased the affected lots may request a full refund or a replacement in corrected packaging. The company can be reached at (714) 660-1031.

Published by GSM · USA (original Chinese edition)

Photo: ElsBrinkerink, CC BY-SA 3.0, via Wikimedia Commons

Latest in Life